← Evidence map

ArticleOncology and therapy2025

Oncotype DX Recurrence Score and Germline BRCA Variants in Patients with HR-Positive/HER2-Negative Early Breast Cancer: A Retrospective Observational Study.

Stefania Morganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Oncotype DX Recurrence Score and Germline BRCA Variants in Patients with HR-Positive/HER2-Negative Early Breast Cancer: A Retrospective Observational Study. | OpenQuestion